Before Surgery or Endoscopy: Why Your GLP-1 Matters

Here is a scenario that plays out in pre-op holding areas every day: a patient scheduled for a routine endoscopy or elective surgery mentions they are on Ozempic. The anesthesiologist pauses. Questions follow. Was the dose held? When was the last injection? Did the patient eat anything solid in the past 24 hours? The concern is not theoretical. GLP-1 receptor agonists slow gastric emptying, sometimes substantially, and that changes the risk calculus for any procedure involving sedation or general anesthesia. If there is food or liquid still in your stomach when you go under, it can come back up and enter your lungs. That is pulmonary aspiration, and it is one of the most dangerous complications in anesthesia.

Why does delayed gastric emptying matter for surgery and anesthesia?

Under normal conditions, the stomach empties a solid meal within about 4 to 5 hours. That is why the standard pre-operative fasting instruction (often called 'NPO after midnight') works: by the time your morning procedure rolls around, your stomach should be empty. Anesthesia suppresses the protective reflexes that keep stomach contents out of your airway. If your stomach is not empty, gastric contents can travel up the esophagus and into the lungs during intubation, extubation, or deep sedation.

Pulmonary aspiration is uncommon in healthy fasting patients (roughly 1 in 3,000 to 1 in 10,000 general anesthetics), but when it happens, the consequences can be severe. Aspiration pneumonitis, chemical burns to the lung tissue, respiratory failure, and death are all documented outcomes. The mortality rate for clinically significant aspiration events is estimated at around 5% (Saraswat, Indian Journal of Anaesthesia, 2015).

GLP-1 receptor agonists change this risk equation because they slow gastric emptying as part of their mechanism of action. A patient who followed standard NPO fasting guidelines may still have solid food in their stomach 12, 18, or even 24 hours after eating if the GLP-1 effect is strong enough. Several anesthesiology case reports published in 2023 and 2024 documented exactly this: patients who fasted appropriately but were found to have significant residual gastric contents at the time of their procedure (Silveira et al., Canadian Journal of Anesthesia, 2023).

What do the ASA guidelines say about holding GLP-1s before procedures?

In June 2023, the American Society of Anesthesiologists (ASA) released a consensus-based guidance statement addressing GLP-1 receptor agonists and elective procedures. This was updated in 2024. The core recommendations are as follows.

It is worth understanding that these guidelines are consensus-based, not derived from randomized controlled trials. There have been no large studies specifically testing the optimal hold period for GLP-1 medications. The 7-day recommendation for weekly injectables is based on the drugs' pharmacokinetics (semaglutide has a half-life of approximately 7 days, tirzepatide approximately 5 days) and the clinical reasoning that one full half-life should meaningfully reduce the gastric emptying effect. Some institutions have adopted more conservative protocols.

How long should you hold each GLP-1 medication before surgery?

The hold times differ based on the specific drug and its formulation. Here is a practical summary based on the ASA guidance and common institutional protocols.

If you take your weekly injection on Fridays and your surgery is scheduled for the following Thursday, that is only 6 days. You should skip that Friday dose to ensure a full 7-day window. Discuss the exact timing with both your prescriber and your surgical or procedural team.

What should you tell your anesthesiologist about your GLP-1?

Be specific. Saying 'I take Ozempic' is a start, but your anesthesia team needs more detail to make informed decisions.

Your anesthesiologist may decide to use point-of-care gastric ultrasound to assess whether your stomach has residual contents. This is a quick, bedside scan that can visualize fluid or solid material in the stomach. It is increasingly used in the GLP-1 context and can help determine whether to proceed, delay, or modify the anesthetic technique (Perlas et al., Anesthesiology, 2011).

What is the liquid diet bridge and how does it reduce risk?

The 'liquid diet bridge' is a practical strategy for reducing gastric residual volume when there is concern about incomplete gastric emptying. The concept is straightforward: even if your gastric emptying is slowed by a GLP-1, liquids still empty faster than solids. Clear liquids empty fastest of all.

A typical liquid diet bridge protocol involves switching to clear liquids only for 24 hours before the procedure, on top of whatever the standard NPO instructions are. Some institutions recommend a full liquid diet (including protein shakes and smooth soups) for 24 to 48 hours before the procedure, then clear liquids only for the final 8 to 12 hours, then NPO as instructed.

This approach is not a substitute for holding the GLP-1 medication. It is an additional safety layer. If you held your medication for 7 days AND followed a liquid diet bridge for 24 hours, the probability of significant residual gastric contents is substantially lower than either measure alone.

Does your GLP-1 affect colonoscopy prep?

Yes, and this is an area that gets less attention than it should. Colonoscopy requires a thoroughly cleaned-out colon, which is achieved through a prep regimen (usually a large-volume polyethylene glycol solution like GoLYTELY, or a split-dose prep). The prep works by flushing liquid through the entire GI tract.

The problem for GLP-1 patients is twofold. First, if gastric emptying is delayed, the prep solution itself may sit in the stomach longer than expected, making the patient more nauseated and reducing the volume that reaches the colon in the expected timeframe. Second, any solid food that was still in the stomach when the prep started will eventually enter the colon during the prep process, potentially degrading prep quality.

A 2024 retrospective study by Sheraton et al. published in Gastrointestinal Endoscopy found that patients on GLP-1 agonists had a statistically significant increase in inadequate bowel prep compared to controls (18.5% vs. 12.3%, p = 0.02). Inadequate prep means the gastroenterologist cannot visualize the colon well enough to detect polyps reliably, which may necessitate a repeat procedure.

Practical steps to improve colonoscopy prep on a GLP-1 include starting a low-residue diet 3 to 5 days before the procedure (instead of the standard 1 to 2 days), switching to clear liquids 48 hours before instead of the typical 24, and using a split-dose prep protocol if your gastroenterologist has not already prescribed one. Split-dose prep (half the evening before, half early the morning of) consistently produces better prep quality than evening-only prep, and this advantage is even more important when gastric emptying is slowed.

What helps with pre-procedure planning on a GLP-1?

The most important thing you can do is plan ahead. If you know a procedure is coming, coordinate the timing of your GLP-1 dose so that the hold period aligns naturally. For a weekly injection, this might mean simply shifting your injection day by a few days one cycle before the procedure.

Keep a clear record of your medication schedule, including exact dates and doses. Tools like GLP1Gut can help you track your GLP-1 dosing schedule and any GI symptoms in the weeks leading up to a procedure, giving your anesthesia and surgical teams the information they need to make the best decisions for your safety.

Finally, do not be afraid to advocate for yourself. If you mention your GLP-1 and the response is dismissive or unfamiliar, ask to speak with the anesthesiologist directly. Awareness of these guidelines has improved enormously since 2023, but it is not yet universal across all surgical centers and outpatient endoscopy suites.

The bottom line on GLP-1s and procedural safety

GLP-1 medications are safe for long-term use in the vast majority of patients, but they change the rules for pre-procedural preparation. The standard 'nothing to eat after midnight' may not be enough when your stomach is emptying more slowly than normal. Holding the medication, extending your fasting window, considering a liquid diet bridge, and communicating clearly with your procedural team are all straightforward steps that meaningfully reduce a real (if still uncommon) risk.

The ASA guidelines exist for a reason. They are not about being overly cautious. They are about matching the preparation to the pharmacology. Your medication is doing its job by slowing your stomach. Your job before a procedure is to make sure everyone involved in your care knows that, and plans accordingly.